Journal
EPIGENOMICS
Volume 12, Issue 2, Pages 157-169Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/epi-2019-0165
Keywords
cancer; cancer-associated fibroblasts; epigenetic; microenvironment
Categories
Funding
- Ligue contre le Cancer
- Region Bretagne
- Fondation ARC pour la Recherche sur le Cancer
- La Ligue contre le Cancer
- Universitede Rennes 1
- CALYS [INCA PLBIO 17-219]
Ask authors/readers for more resources
The tumor microenvironment (TME) plays a central role in tumor development and drug resistance. Within TME, the stromal cell subset, called cancer-associated fibroblasts, is a heterogeneous population originating from poorly characterized precursors. Since cancer-associated fibroblasts do not acquire somatic mutations, other mechanisms like epigenetic regulation, could be involved in the development of these cells and in the acquisition of tumor supportive phenotypes. Moreover, such epigenetic modulations have been correlated to the emergence of an immunosuppressive microenvironment facilitating tumor evasion. These findings underline the need to deepen our knowledge on epigenetic mechanisms driving TME development and function, and to understand the impact of epigenetic drugs that could be used in future to target both tumor cells and their TME.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available